![N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide in PDB entry 4yfn, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/4yfn_entity_8_side_image-200x200.png "Hetero hexameric assembly 1 of PDB entry <span class='highlight'>4yfn</span> contains 1 copy of <span class='highlight'>N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide</span>. Side view.")
![N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide in PDB entry 4yfn, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/4yfn_entity_8_top_image-200x200.png "Hetero hexameric assembly 1 of PDB entry <span class='highlight'>4yfn</span> contains 1 copy of <span class='highlight'>N-[3,4-dioxo-2-(4-{[4-(trifluoromethyl)benzyl]amino}piperidin-1-yl)cyclobut-1-en-1-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide</span>. Top view.")
Environment details NEW
4C2 2004 bound to chain D
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.